0001628280-23-000422.txt : 20230105
0001628280-23-000422.hdr.sgml : 20230105
20230105131248
ACCESSION NUMBER: 0001628280-23-000422
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230103
FILED AS OF DATE: 20230105
DATE AS OF CHANGE: 20230105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Daly James M
CENTRAL INDEX KEY: 0001560782
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36783
FILM NUMBER: 23510440
MAIL ADDRESS:
STREET 1: INCYTE CORPORATION EXPERIMENTAL STATION
STREET 2: RTE 141 & HENRY CLAY RD. BLDG E336
CITY: WILMINGTON
STATE: DE
ZIP: 19880
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001358403
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201450200
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3730 KIRBY DRIVE
STREET 2: SUITE 1200
CITY: HOUSTON
STATE: TX
ZIP: 77098
BUSINESS PHONE: (832) 384-1100
MAIL ADDRESS:
STREET 1: 3730 KIRBY DRIVE
STREET 2: SUITE 1200
CITY: HOUSTON
STATE: TX
ZIP: 77098
FORMER COMPANY:
FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060405
4
1
wf-form4_167294235465620.xml
FORM 4
X0306
4
2023-01-03
0
0001358403
BELLICUM PHARMACEUTICALS, INC
BLCM
0001560782
Daly James M
C/O BELLICUM PHARMACEUTICALS, INC.
3730 KIRBY DRIVE, SUITE 1200
HOUSTON
TX
77098
1
0
0
0
Common Stock
2023-01-03
4
M
0
60414
0
A
109873
D
The Reporting Person was granted Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of BLCM common stock. The RSUs vest in full on January 3, 2024, the one-year anniversary of the grant date.
/s/ Richard A. Fair, Attorney-in-Fact
2023-01-05